Nishimura R, Okada Y, Kuroda A, Suzuki J, Hirota Y, Matsuhisa M, Ishiguro M, Ohno T, Suganuma Y, Tanaka K, Tone A, Yamamoto A, Yoshida S, Report of the Committee on the Development of a Consensus Statement Regarding Novel Glycemic Indices Derived from Advanced Medical Devices. Consensus statement on novel glucose-related metrics obtained through advanced medical devices. J Jpn Diabetes Soc. 2024;67:369–86.

Google Scholar 

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;29:977–86.

Google Scholar 

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.

Article  Google Scholar 

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103–17.

Article  CAS  PubMed  Google Scholar 

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42:1593–603.

Article  PubMed  PubMed Central  Google Scholar 

Monnier L, Colette C, Wojtusciszyn A, Dejager S, Renard E, Molinari N, Owens DR. Toward defining the threshold between low and high glucose variability in diabetes. Diabetes Care. 2017;40:832–8.

Article  CAS  PubMed  Google Scholar 

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer S, Phillip M. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631–40.

Article  PubMed  PubMed Central  Google Scholar 

Su G, Mi SH, Tao H, Li Z, Yang HX, Zheng H, Zhou Y, Tian L. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care. 2013;36:1026–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23:1143–8.

Article  CAS  PubMed  Google Scholar 

Rebel A, Rice MA, Fahy BG. Accuracy of point-of-care glucose measurements. J Diabetes Sci Technol. 2012;6:396–411.

Article  PubMed  PubMed Central  Google Scholar 

Freckmann G, Pleus S, Grady M, Setford S, Levy B. Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices. J Diabetes Sci Technol. 2019;13:575–83.

Article  CAS  PubMed  Google Scholar 

Japan Diabetes Society. On “Guidelines for the proper use of real-time CGM”. 2023. http://www.jds.or.jp/modules/important/index.php?content_id=111.

Abbott Japan LLC. Differences between CGM vs BGM | FreeStyle Libre Systems. 2023. https://www.freestyle.abbott/us-en/cgm-vs-bgm.html.

Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52:2790–4.

Article  CAS  PubMed  Google Scholar 

Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl 2):B21–9.

PubMed  Google Scholar 

Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39:1577–83.

Article  CAS  PubMed  Google Scholar 

Beck RW, Bergenstal RM, Cheng P, Kollman C, Carlson AL, Johnson ML, Rodbard D. The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol. 2019;13:614–26.

Article  PubMed  PubMed Central  Google Scholar 

Raj R, Mishra R, Jha N, Joshi V, Correa R, Kern PA. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review. BMJ Open Diabetes Res Care. 2022;10: e002573.

Article  PubMed  PubMed Central  Google Scholar 

Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C, Li Z, Brown AS, Close KL. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42:400–5.

Article  CAS  PubMed  Google Scholar 

El Malahi A, Van Elsen M, Charleer S, Dirinck E, Ledeganck K, Keymeulen B, Crenier L, Radermecker R, Taes Y, Vercammen C, Nobels F, Mathieu C, Gillard P, De Block C. Relationship between time in range, glycemic variability, HbA 1 c, and complications in adults with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2022;107:e570–81.

Article  PubMed  Google Scholar 

Mesa A, Giménez M, Pueyo I, Perea V, Viñals C, Blanco J, Vinagre I, Serés-Noriega T, Boswell L, Esmatjes E, Conget I, Amor AJ. Hyperglycemia and hypoglycemia exposure are differentially associated with micro- and macrovascular complications in adults with Type 1 Diabetes. Diabetes Res Clin Pract. 2022;189: 109938.

Article  CAS  PubMed  Google Scholar 

Lu J, Ma X, Shen Y, Wu Q, Wang R, Zhang L, Mo Y, Lu W, Zhu W, Bao Y, Vigersky RA, Jia W, Zhou J. Time in range is associated with carotid intima-media thickness in type 2 diabetes. Diabetes Technol Ther. 2020;22:72–8.

Article  CAS  PubMed  Google Scholar 

Lu J, Wang C, Shen Y, Chen L, Zhang L, Cai J, Lu W, Zhu W, Hu G, Xia T, Zhou J. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care. 2021;44:549–55.

Article  CAS  PubMed  Google Scholar 

Selvin E. The prognostic value of time in range in type 2 diabetes. Diabetes Care. 2021;44:319–20.

Article  PubMed  PubMed Central  Google Scholar 

Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler JS, Snoek FJ, Weinstock RS, Peters AL. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44:2589–625.

Article  CAS  PubMed  Google Scholar 

Vigersky RA, McMahon C. The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Diabetes Technol Ther. 2019;21:81–5.

Article  CAS  PubMed  Google Scholar 

Advani A. Positioning time in range in diabetes management. Diabetologia. 2020;63:242–52.

Article  PubMed  Google Scholar 

Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, DIAMONDStudyGroup. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317:371–8.

Article  CAS  PubMed  Google Scholar 

Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH. Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the Mini-Med 670G system. Diabetes Care. 2018;41:789–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV, Kaufman FR. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316:1407–8.

Article  PubMed  Google Scholar 

Collyns OJ, Meier RA, Betts ZL, Chan DSH, Frampton C, Frewen CM, Hewapathirana NM, Jones SD, Roy A, Grosman B, Kurtz N, Shin J, Vigersky RA, Wheeler BJ, de Bock MI. Improved glycemic outcomes with Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care. 2021;44:969–75.

Article  CAS  PubMed  Google Scholar